Histone deacetylases (HDACs): characterization of the classical HDAC family

被引:2467
作者
De Ruijter, AJM [1 ]
Van Gennip, AH [1 ]
Caron, HN [1 ]
Kemp, S [1 ]
Van Kuilenburg, ABP [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, Dept Paediat,Emma Childrens Hosp & Clin Chem, NL-1100 DE Amsterdam, Netherlands
关键词
characterization; inhibitor; co-repressor; gene expression; histone deacetylase; tissue distribution;
D O I
10.1042/BJ20021321
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcriptional regulation in eukaryotes occurs within a chromatin setting, and is strongly influenced by the posttranslational modification of histones, the building blocks of chromatin, such as methylation, phosphorylation and acetylation. Acetylation is probably the best understood of these modifications: hyperacetylation leads to an increase in the expression of particular genes, and hypoacetylation has the opposite effect. Many studies have identified several large, multisubunit enzyme complexes that are responsible for the targeted deacetylation of histones. The aim of this review is to give a comprehensive overview of the structure, function and tissue distribution of members of the classical histone deacetylase (HDAC) family, in order to gain insight into the regulation of gene expression through HDAC activity. SAGE (serial analysis of gene expression) data show that HDACs are generally expressed in almost all tissues investigated. Surprisingly, no major differences were observed between the expression pattern in normal and malignant tissues. However, significant variation in HDAC expression was observed within tissue types. HDAC inhibitors have been shown to induce specific changes in gene expression and to influence a variety of other processes, including growth arrest, differentiation, cytotoxicity and induction of apoptosis. This challenging field has generated many fascinating results Which will ultimately lead to a better understanding of the mechanism of gene transcription as a whole.
引用
收藏
页码:737 / 749
页数:13
相关论文
共 127 条
[111]   Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase [J].
Warrell, RP ;
He, LZ ;
Richon, V ;
Calleja, E ;
Pandolfi, PP .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (21) :1621-1625
[112]   Structurally simple trichostatin A-like straight chain hydroxamates as potent histone deacetylase inhibitors [J].
Woo, SH ;
Frechette, S ;
Abou Khalil, E ;
Bouchain, G ;
Vaisburg, A ;
Bernstein, N ;
Moradei, O ;
Leit, S ;
Allan, M ;
Fournel, M ;
Trachy-Bourget, MC ;
Li, ZM ;
Besterman, JM ;
Delorme, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (13) :2877-2885
[113]   SMRTe inhibits MEF2C transcriptional activation by targeting HDAC4 and 5 to nuclear domains [J].
Wu, XY ;
Li, H ;
Park, EJ ;
Chen, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) :24177-24185
[114]   Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer [J].
Yan, L ;
Yang, XW ;
Davidson, NE .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2001, 6 (02) :183-192
[115]   Sodium butyrate induces transcription from the Gαi2 gene promoter through multiple Sp1 sites in the promoter and by activating the MEK-ERK signal transduction pathway [J].
Yang, JQ ;
Kawai, Y ;
Hanson, RW ;
Arinze, IJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :25742-25752
[116]   Functional domains of histone deacetylase-3 [J].
Yang, WM ;
Tsai, SC ;
Wen, YD ;
Fejér, G ;
Seto, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (11) :9447-9454
[117]  
Yang XW, 2001, CANCER RES, V61, P7025
[118]   Regulation of transcription factor YY1 by acetylation and deacetylation [J].
Yao, YL ;
Yang, WM ;
Seto, E .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (17) :5979-5991
[119]  
YOSHIDA M, 1990, J BIOL CHEM, V265, P17174
[120]   Histone deacetylase as a new target for cancer chemotherapy [J].
Yoshida, M ;
Furumai, R ;
Nishiyama, M ;
Komatsu, Y ;
Nishino, N ;
Horinouchi, S .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (Suppl 1) :S20-S26